XOMAP XOMA Corporation
Healthcare$25.36+0.08%ClosedMarket Cap: $305.9M
As of 2026-05-26
Valuation
P/E (TTM)
21.09
PEG
0.03
P/B
4.40
P/S
14.44
EV/EBITDA
13.22
DCF Value
$-59.65
FCF Yield
1.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
93.3%
Operating Margin
13.7%
Net Margin
87.0%
ROE
30.2%
ROA
11.6%
ROIC
1.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $12.3M | 92.7% | $-480.0K | $4.5M | $— | $0.54 |
| Q4 null | $1.4M | 100.0% | $2.2M | $6.1M | $— | $0.54 |
| FY null | $52.1M | 94.3% | $11.4M | $31.7M | $— | $2.16 |
| Q3 null | $532.0K | 100.0% | $-1.3M | $14.1M | $— | $0.54 |
| Q2 null | $13.1M | 95.0% | $4.6M | $9.2M | $— | $0.54 |
| Q1 null | $15.9M | 91.9% | $5.9M | $2.4M | $— | $0.54 |
| Q4 null | $8.7M | 97.7% | $-16.3M | $-4.0M | $— | $0.54 |
| FY null | $28.5M | 99.3% | $-40.0M | $-13.8M | $— | $2.16 |
| Q3 null | $7.2M | 100.0% | $-15.6M | $-17.2M | $— | $0.54 |
| Q2 null | $11.1M | 89.5% | $-10.1M | $16.0M | $— | $0.54 |
| Q1 null | $1.5M | 99.9% | $-7.0M | $-8.6M | $— | $0.54 |
| Q4 2023 | $1.8M | 98.6% | $-19.9M | $-20.1M | $-1.87 | $0.54 |